AR105775A1 - THERAPEUTIC VACCINES AGAINST HPV18 - Google Patents

THERAPEUTIC VACCINES AGAINST HPV18

Info

Publication number
AR105775A1
AR105775A1 ARP160102553A ARP160102553A AR105775A1 AR 105775 A1 AR105775 A1 AR 105775A1 AR P160102553 A ARP160102553 A AR P160102553A AR P160102553 A ARP160102553 A AR P160102553A AR 105775 A1 AR105775 A1 AR 105775A1
Authority
AR
Argentina
Prior art keywords
vaccines against
therapeutic vaccines
against hpv18
hpv18
nucleic acid
Prior art date
Application number
ARP160102553A
Other languages
Spanish (es)
Inventor
Khan Selina
Gilles Uil Taco
Oosterhuis Koen
Christiaan Scheper Gerrit
H H V Custers Jerme
Margaretha Bunnik Evelien
Original Assignee
Janssen Vaccines & Prevention Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Vaccines & Prevention Bv filed Critical Janssen Vaccines & Prevention Bv
Publication of AR105775A1 publication Critical patent/AR105775A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Construcciones de ácidos nucleicos y polipéptidos de diseño que se pueden utilizar como vacunas terapéuticas contra el HPV18 y/o el HPV16. Reivindicación 1: Una molécula de ácido nucleico caracterizada porque codifica para un primer polipéptido que comprende la secuencia de aminoácidos que se establece en SEQ ID Nº 20.Nucleic acid and polypeptide design constructs that can be used as therapeutic vaccines against HPV18 and / or HPV16. Claim 1: A nucleic acid molecule characterized in that it encodes a first polypeptide comprising the amino acid sequence set forth in SEQ ID No. 20.

ARP160102553A 2015-08-20 2016-08-19 THERAPEUTIC VACCINES AGAINST HPV18 AR105775A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15181791 2015-08-20

Publications (1)

Publication Number Publication Date
AR105775A1 true AR105775A1 (en) 2017-11-08

Family

ID=53938205

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160102553A AR105775A1 (en) 2015-08-20 2016-08-19 THERAPEUTIC VACCINES AGAINST HPV18

Country Status (1)

Country Link
AR (1) AR105775A1 (en)

Similar Documents

Publication Publication Date Title
AR102527A1 (en) THERAPEUTIC VACCINES FOR HPV16
CL2018000432A1 (en) Therapeutic vaccines against hpv18
CR20170282A (en) NEW PEPTIDES AND NEW COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (CHC) AND OTHER TYPES OF CANCER
CR20170419A (en) NEW PEPTIDES AND NEW COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCER CANCER AND OTHER TYPES OF CANCER.
CL2017001070A1 (en) Variants of interferon a2b
MX2018011425A (en) Dna antibody constructs and method of using same.
EA201692025A1 (en) DELIVERY OF PROTEINS, BASED ON BACTERIA
CL2016001405A1 (en) A peptide mixture
ES2721309T3 (en) Composition for preparing tagatose and method for preparing tagatose from fructose
SG11202104875XA (en) Immunogenic peptides with improved oxidoreductase motifs
AR102950A1 (en) LIPASE AND POLINUCLEOTIDE VARIANTS CODING THEM
MX2016013631A (en) Modified host cells and uses thereof.
AR120721A2 (en) PEPTIDES AND COMPOSITIONS FOR THE TREATMENT OF JOINT DAMAGE
UY36617A (en) IMMUNOGENIC FUSION PROTEINS FOR CANCER TREATMENT
MX2017006625A (en) Pneumolysin mutants and methods of use thereof.
BR112018072372A2 (en) hpv therapeutic vaccine combinations
TW201612190A (en) Flavivirus virus like particle
CO2017011964A2 (en) A method to produce recombinant hcg
AR102410A1 (en) POLYPEPTIDES THAT HAVE XILANASE ACTIVITY WITH A HIGH CONVERSION RATE OF POLYSACARIDS CONTAINING XYLOSA
AR102919A1 (en) LIPASE AND POLINUCLEOTIDE VARIANTS CODING THEM
PE20230495A1 (en) VACCINATION WITH THE ALPHA 3 DOMAIN OF MICA/B FOR THE TREATMENT OF CANCER
BR112017003228A2 (en) chromobacterium subtsugae genes
EP4226937A3 (en) Non-neuroinvasive viruses and uses thereof
AR108688A1 (en) YEAST VACCINE VECTOR INCLUDING IMMUNE STIMULATING AND ANTIGEN POLYPEPTIDES, METHODS FOR USE
EA201791156A1 (en) Sequences of oligonucleotides for use in the construction of pathways